
With Livongo, did Zane Burke sell a lemon to Teladoc’s Jason Gorevic?
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
Was Livongo a good business? As Burke, now CEO of Quantum Health, touts its strength to investors ahead of a potential IPO, should the Livongo-Teladoc history give them pause?
To help address the diabetes epidemic, providers should incorporate remote patient monitoring into the standard of care, according to Kaiser Permanente physician Dr. Sos Mboijana. When treating chronic conditions like diabetes, having access to a continuous flow of patient data is critical, he said.
Ochsner Health recently released the results of its digital health pilot program for Medicaid patients with hypertension and type 2 diabetes. The program, which combines remote patient monitoring with personalized care teams, did an efficient job at bringing down patients’ blood pressure and hemoglobin A1c levels.
Should we start treating menopause as a disease condition? In our view, it's a chronic disease condition that can go beyond two decades for some women, resulting in silent suffering.
Of all systematic changes to healthcare, these four adjustments would be easy enough to roll out quickly and would have a massive impact on the country’s health outcomes
By following the patient at each stage of its disease progression, from diagnosis to disease management, and integrating a variety of technologies, digital health provides deeper insights and help for care management.
As telehealth has become a bigger part of the healthcare system, focusing on access is important, but quality of care matters, too. When digital health platforms are thoughtful, innovative, and focused on delivering quality care, they can offer a more inspiring vision for the future of healthcare.
Telehealth utilization has dropped as the pandemic emergency has waned. For telehealth utilization to meet the higher expectations set during the pandemic, the technology must be wielded for more than just episodic or urgent care.
The startup's Cordella Pulmonary Artery Pressure Sensor System, which was implanted in 70 heart failure patients in Europe, led to low hospitalization rates and high patient compliance with daily measurements needed to monitor them remotely.
Working behind the scenes to examine what motivates us and what we respond to best, behavioral science applied to AI-powered technologies can create personalized success companions that aid people in making small but important steps along difficult health journeys.
The startup's asthma solution, called Mya, combines home-based diagnostics, digital health and a care team to identify patients at risk and proactively intervene to prevent asthma attacks.
The Series D funding round was led by growth equity firm Stripes. Hello Heart's latest haul brings the total amount the company has raised since its founding in 2013 to $138 million.
With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.
Early indications show that remote patient monitoring holds promise in advancing value-based care. But healthcare providers and practice managers need to consider several factors before they begin to integrate RPM and wearables into their practices and decision-making processes.
Getting patients to quit and remain tobacco-free requires ongoing treatment that’s customized, flexible, easy to use, and free to the user. Primary care providers are well versed in the management of chronic, treatable conditions. It’s time for primary care doctors to light the way toward getting patients to quit tobacco.